Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,189,330
+$10,388,312 QoQ
Shares Held
24,336
+19.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#732
of 4,605 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oak Grove Capital LLC holds $61,174,074 across 4 Drug Manufacturers - General names. LLY ranks #1 (47.7% of the industry book) .
All Filings in LLY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,189,330 | 24,336 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $18,801,018 | 20,441 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $21,891,233 | 20,370 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $19,091,786 | 25,022 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,859,117 | 38,304 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $60,046,960 | 72,704 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $74,210,044 | 96,127 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $78,003,473 | 88,046 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $73,450,763 | 81,127 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $64,651,587 | 83,104 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $39,606,499 | 67,945 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $33,600,167 | 62,555 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $28,370,007 | 60,493 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $17,750,006 | 51,686 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $9,905,118 | 27,075 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,041,875 | 12,500 | Shares | Sole | 2022-11-01 | |
| No filing history on record for this holder in this stock. | ||||||